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Analysis of the proteome of human airway
epithelial secretions
Mehboob Ali1,3†, Erik P Lillehoj2†, Yongsung Park1, Yoshiyuki Kyo1, K Chul Kim1*
Abstract
Background: Airway surface liquid, often referred to as mucus, is a thin layer of fluid covering the luminal surface
that plays an important defensive role against foreign particles and chemicals entering the lungs. Airway mucus
contains various macromolecules, the most abundant being mucin glycoproteins, which contribute to its defensive
function. Airway epithelial cells cultured in vitro secrete mucins and nonmucin proteins from their apical surface
that mimics mucus production in vivo. The current study was undertaken to identify the polypeptide constituents
of human airway epithelial cell secretions to gain a better understanding of the protein composition of respiratory
mucus.
Results: Fifty-five proteins were identified in the high molecular weight fraction of apical secretions collected from
in vitro cultures of well-differentiated primary human airway epithelial cells and isolated under physiological
conditions. Among these were MUC1, MUC4, MUC5B, and MUC16 mucins. By proteomic analysis, the nonmucin
proteins could be classified as inflammatory, anti-inflammatory, anti-oxidative, and/or anti-microbial.
Conclusions: Because the majority of the nonmucin proteins possess molecular weights less than that selected for
analysis, it is theoretically possible that they may associate with the high molecular weight and negatively charged
mucins to form a highly ordered structural organization that is likely to be important for maintaining the proper
defensive function of airway mucus.
Background
Mucins are a heterogeneous group of polydisperse and
high molecular weight O-glycosylated proteins, ranging
from 300,000 to >1 × 107 Da [1]. Mucin genes encode
polypeptide monomers that are synthesized as rod-shape
apomucin cores and are post-translationally modified by
exceptionally abundant and terminally sialylated glycan
moieties. Mucins are secreted or inserted to the apical
surface membrane of epithelial cells via a membrane-
spanning hydrophobic domain [2,3]. Secreted mucins
constitute the most abundant glycoprotein component
of mucus, a gel-like substance that covers all wet-sur-
faced epithelia, including those of the respiratory, gas-
trointestinal, and genitourinary tracts [4-7]. Eighteen
mucin (MUC) genes have been cloned, 12 of which are
expressed in the respiratory tract [3]. Airway secreted
mucins (MUC2, 5AC, 5B, 7, 8, 11, 13, 19, and 20) are
produced by goblet cells on the surface epithelium and
mucous cells from sub-mucosal glands [4,5,7]. Mem-
brane-associated mucins in the airways include MUC1,
MUC4, and MUC16. Mucin gene and protein struc-
tures, goblet cell mucin secretion and hypersecretion in
airway diseases as well as the regulation of goblet cell
hyperplasia have been well-documented in the literature
[7-9]. However, the complex interactions between
mucins and other protein components of airway mucus
remain to be elucidated.
In vitro cultures of human and animal airway epithe-
lial cells have been used to characterize mucin produc-
tion under various experimental conditions. Human cell
cultures from tracheal glands were reported to express a
mixed serous and mucous phenotype [10,11]. Normal
and cystic fibrosis cells from human tracheal glands iso-
lated by the explant/outgrowth procedure secreted high
molecular weight mucin-like glycoproteins and
expressed the MUC2 gene [12]. The development and
characterization of primary cell cultures from tracheal
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surface epithelium [13] that were highly enriched for
secretory cells allowed the first identification of authen-
tic airway mucins that were produced in vitro [14]. Con-
fluent cultures of hamster tracheal epithelial cells
cultured on a type I collagen gel synthesized and
secreted high molecular weight glycoconjugates which
eluted in the void volume upon Sepharose CL-4B col-
umn chromatography [14,15]. Biochemical analysis of
these mucous glycoproteins showed both size and
charge microheterogeneities that were remarkably simi-
lar to those of mucins produced in vivo.
The in vitro model of mucin production by airway
epithelial cell cultures first established in hamsters was
subsequently extended to guinea pig and human airway
epithelium [16,17]. Proteomic studies have revealed that
the protein composition of in vitro human airway epithe-
lial cell secretions is particularly complex. Candiano et al.
[18] used a two-dimensional SDS-PAGE/proteomics
approach to identify the proteins secreted by in vitro cul-
tures of polarized monolayers of human airway epithelial
cells at resting and following stimulation with IL-4, IL-
1b, TNF-a, or IFN-g. Approximately 175 polypeptides
were identified, among which were immune-related pro-
teins, structural proteins, proteases, and protease inhibi-
tors. Comparisons between treated and untreated
conditions showed that the expression of several proteins
was significantly modified by the different cytokines.
Kesimer et al. [19] identified 134 proteins from apical
secretions of primary airway epithelial cells, with 84 pro-
teins (62.7%) being common with the proteins identified
in in vivo human tracheobronchial sputum. Separation of
the proteins by density gradient ultracentrifugation in the
presence of 4 M guanidine hydrochloride identified 29
proteins that were present in the high-density, mucin-
rich fraction. The nonmucin proteins in this fraction
were also present in the lower-density pool, suggesting to
the authors that they associated and copurified with the
mucins. However, given that the proteins were isolated
under denaturing conditions, the current study was con-
ducted to identify mucin-associated proteins in in vitro
human airway epithelial cell secretions isolated under
more physiological conditions.
Methods
Preparation of human airway epithelial cell secretions
(hAECS)
Primary normal human bronchial epithelial (NHBE) cells
and culture media were purchased from MatTek Corp.
(Ashland, MA). Air-liquid interface (ALI) cell cultures
were maintained according to the manufacturer’s protocol.
The cells were seeded and incubated for 2 days at 37°C as
submerged cultures before ALI culture was initiated. At
confluence, the apical surface of the culture was washed
with culture medium and the collected medium was
referred to as hAECS. hAECS were collected daily for
5 days from multiple independent cultures of NHBE cells
reflecting different cell donors and were pooled so that the
data could not be attributed to artifacts of a single donor’s
genotype. Pooled samples were dialyzed against 100-fold
volume of distilled water at 4°C for 2 days to approxi-
mately 5 mOsm/L, lyophilized, and stored at -80°C.
Gel filtration chromatography
Approximately 1.80 mg of hAECS protein in 2.5 ml was
separated on a Sepharose CL-4B gel filtration column
(3.0 × 50 cm), pre-calculated for the void volume (V0)
and total volume (Vt) fractions with dextran blue and
phenol red respectively. Proteins were applied and
eluted in PBS, pH 7.2 with elution monitored by absor-
bance at 280 nm (A280). The V0 fractions containing
high molecular weight mucins and associated proteins
were collected, assayed for carbohydrate content by
reaction with Periodic acid-Schiff reagents, and stored at
-20°C until use.
Periodic acid-Schiff carbohydrate assay
The Periodic acid-Schiff staining kit from Sigma (St.
Louis, MO) was used to determine carbohydrate content
according to the manufacturer’s instructions. Briefly, 180
μl of sample was added to wells of a 96-well plate, fol-
lowed by the addition of 20 μl of periodic acid solution,
incubation at 37°C for 1 hr, addition of 20 μl of Schiff’s
reagent, and incubation at room temperature for 30
min. A555 was measured using a spectrophotometer.
MUC5AC Westen blot assay
Samples were diluted in 1:4 in 40 mM Tris-acetate, pH
8.0 containing 40% glycerol and 0.8% bromophenol blue
and heated at 100°C for 5 min. Samples were electro-
phoresed in 1.0% agarose gels (12 × 12 cm) using 40 mM
Tris-acetate, pH 8.0 containing 1.0 mM EDTA and 0.1%
SDS at 30 V for 20 hr at room temperature. After electro-
phoresis, the agarose gels were incubated with transfer
buffer (0.06 M sodium citrate, pH 7.0, 0.6 M NaCl) for
30 min and proteins were transferred to PVDF mem-
brane overnight by the capillary blotting. The membrane
was blocked with PBS containing 0.5% Tween 20 for 1
hr, sequentially incubated overnight with primary anti-
MUC5AC monoclonal antibody (1:2,000; 45 M1, Gen-
Way Biotech, San Diego, CA), 1 hr with goat anti-mouse
IgG secondary antibody (1:10,000; KPL, Gaithersburg,
MD), and enhanced chemiluminescence substrate
(Amersham GE Healthcare, Piscataway, NJ).
Proteomics analysis
TCA precipitation of V0 fractions
V0 fractions were precipitated by addition of a 4-fold
volume of TCA overnight at 4°C. Samples were
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centrifuged at 15,000 × g for 15 min at 4°C, the pellets
were resuspended in 200 μl of acetone at -20°C, centri-
fuged, and air-dried.
One-dimensional SDS-polyacrylamide gel electrophoresis
TCA precipitated and acetone washed V0 fractions of
hAECS were resuspended in a minimum volume of
30 mM Tris-HCl, pH 8.5-9.0 containing 2 M thiourea, 7
M urea, and 4% CHAPS. Thirty μg of protein was
diluted in an equal volume of SDS-PAGE sample load-
ing buffer (120 mM Tris-HCl, pH 6.8 containing 20%
glycerol, 4% SDS, 200 mM DTT, and 0.01% bromophe-
nol blue). Samples were resolved on one-dimensional
12% SDS-PAGE gels at 20 mA for 30 min and 50 mA
until the bromophenol dye front reached the bottom of
gel. Gels were silver-stained and photographed.
Nano-LC-IT MS
Gel slices obtained along the entire length of the SDS-
PAGE gel were reduced with 10 mM DTT in 50 mM
NH4HCO3 for 30 min at 37°C and alkylated with
50 mM iodoacetamide in 50 mM NH4HCO3 for 30 min
at room temperature in the dark. Gel slices were
destained with 50% (v/v) acetonitrile in 50 mM
NH4HCO3, dehydrated with acetonitrile, and 40 ml of
12.5 mg/ml trypsin in 50 mM NH4HCO3 was added to
cover the gel pieces. Following overnight trypsin diges-
tion, peptides released into solution were desalted, dried
by vacuum centrifugation, and resolubilized in 30 ml of
0.1% (vol/vol) trifluoroacetic acid. The sample was loaded
onto a 2 mg capacity peptide trap (CapTrap; Michrom
Bioresources, Auburn, CA) prior to separation on a C-18
reversed-phase HPLC capillary column (15 cm, 75 mm,
Agilent, Santa Clara, CA) at 300 nl/min delivered by an
Agilent 1100 LC pump. A mobile-phase gradient was run
using mobile phases A (1% acetonitrile/0.1% formic acid)
and B (80% acetonitrile/0.1% formic acid) from 0 to
10 min with 0-15% B, 10-60 min with 15-60% B, and
60-65 min with 60-100% B. Eluted peptides were ana-
lyzed by nanoelectrospray ionization (ESI) tandem mass
spectrometry (MS) using a HCT Ultra ion trap mass
spectrometer (Bruker Daltonics Inc., Billerica, MA). ESI
was delivered using distal-coating spray Silica tip (ID 20
mM, tip inner ID 10 mM, New Objective, Woburn, MA)
at a spray voltage of -1300 V. Using automatic switching
between MS and MS/MS modes, MS/MS fragmentation
was performed on the two most abundant ions on each
spectrum using collision-induced dissociation with active
exclusion (excluded after two spectra and released after 2
min). The entire system was controlled by HyStar 3.1
software.
Data analysis
Mass spectra processing was performed with Data Ana-
lysis 3.3 software and the generated peak list was sub-
mitted to an in-house Mascot (Matrix Science, Boston,
MA) search engine (version 2.2) for searching against
the Swiss-Prot protein database (version 56.6 containing
410,518 sequences). Mascot search parameters were set
as follows: taxonomy human, trypsin enzyme with maxi-
mal 1 missed cleavage, cysteine carboxymethylation as
fixed modification, methionine oxidation as variable
modifications, and 0.30 Da mass tolerance for precursor
peptide ions and 0.4 Da for MS/MS fragment ions. All
peptides matches were filtered with an ion score cutoff
of 10. The following criteria were used for protein iden-
tification: one peptide with ion score 50 or higher, two
or more peptides with one ion score higher than 31
(p < 0.05) and one ion score 20 or higher, and molecu-
lar weight match between theoretical and experimental
values applied for proteins with Mascot scores less than
70. Protein identifications were only accepted and
reported as distinct hits if they were based on at least
one unique peptide that passed probability validation.
Under these criteria, no false positive matches were
found when searched against a reversed-decoy Swiss-
Prot database. Identified proteins were analyzed for
molecular and biological function using the Panther
protein database [20] and literature search using
PubMed.
Results
Gel filtration chromatography of hAECS
Figure 1 shows the Sepharose CL-4B gel filtration profile
of hAECS collected from the apical surface of in vitro
cultures of primary NHBE cells cultured at an ALI. Two
peaks of protein elution were detected by A280, the V0
(fraction 18) and the Vt (fraction 41) (denoted by solid
line). The periodic acid-Schiff assay confirmed the pre-
sence of glycoproteins in the V0 fractions (denoted by
dotted line).
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Figure 1 Sepharose CL-4B gel filtration chromatography of
hAECS. The percent optical densities at 280 nm (solid line) and 555
nm (dashed line) are indicated on the x-axis while individual column
fractions are indicated on the y-axis. The void volume (V0) and total
volume (Vt) are indicated.
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Gel electrophoretic analysis of hAECS proteins
Silver staining of hAECS proteins in the Sepharose CL-
4B V0 fraction that were resolved by one-dimensional
SDS-PAGE showed the presence of multiple protein
bands (Figure 2). Most of the proteins bands were
<75 kDa with a diffuse area of staining at >250 kDa.
Protein identification by nano-LC-IT MS
The hAECS sample resolved by gel filtration chromato-
graphy and SDS-PAGE was divided into ten 0.5 cm gel
slices, each of which was processed as described in the
Methods. Fifty-five proteins were identified (Table 1).
Among these were MUC1, MUC4, MUC5B, and
MUC16 in the high molecular weight region (>250 kDa)
of the acrylamide gel. While MUC5AC was not identi-
fied by proteome analysis, this mucin was readily
detected by Western blotting of hAECS (Figure 3). The
molecular (Figure 4) and biological (Figure 5) functions
of the identified proteins were made using the Panther
protein database search engine. According to molecular
function analysis, most of the identified proteins were
classified as regulatory molecules (20.0%), calcium bind-
ing proteins (16.4%), transfer/carrier proteins (10.9%),
and defense/immunity-related proteins (10.9%). Accord-
ing to biological function analysis, the majority of the
identified proteins belonged to the defense/immunity
(32.7%), protein metabolism and modification (23.6%),
and signal transduction (16.4%) categories. Based on a
combined search of the published literature and the
Panther protein database analysis, the identified proteins
were grouped into 4 major functional subgroups, namely
inflammatory, anti-inflammatory, anti-oxidant, and anti-
microbial (Figure 6).
Discussion
Among the 55 proteins that were identified in the high
molecular weight fraction of hAECS from in vitro cul-
tures of primary NHBE cells collected under physiologi-
cal conditions, 43 (78.2%) were unique to this study and
12 (21.8%) were common to proteins identified in the
mucin-rich apical secretions isolated under denaturing
conditions by Kesimer et al. [19]. The shared proteins
of the two studies are: MUC1, MUC4, MUC5B,
MUC16, CD59, complement C3, clusterin, glutathione
S-transferase, lactotransferrin, long palate, PLUNC
(palate, lung and nasal epithelial clone) protein,
LPLUNC1 (long PLUNC), and the polymeric immuno-
globulin receptor. All of the proteins unique to our
study comprise important inflammatory, anti-inflamma-
tory, anti-microbial and/or anti-oxidant components
that are elicited by the respiratory tract in response to
exposure to infectious or injurious insults [21]. On the
other hand, among the proteins that were identified by
Kesimer et al. [19] but not in this study are alpha-defen-
sin 1 and secretory leukocyte peptidase inhibitor (SLPI),
both of which are thought to have broad-spectrum anti-
biotic activities [22].
While it is tempting to speculate that the proteins we
identified may form a physiologically relevant associa-
tion with mucins, it is important to emphasize that they
may or may not be actively secreted by the cells, or may
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Figure 2 One-dimensional SDS-polyacrylamide gel electro-
phoresis of V0 fraction from gel filtration chromatography.
Proteins were separated on a 12% gel under reducing conditions
and visualized by silver staining. Lane 1, hAECS sample. Lane 2,
prestained molecular weight marker proteins. Molecular weights in
kDa are indicated on the right.
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Table 1 Proteins identified in the V0 fraction of hAECS following SDS-PAGE
Gene Name Protein Name Gel Slicea Ion Scoreb Mol Wt (Da)c Matchesd
A2AP_HUMAN Alpha-2-antiplasmin 3-4 57 54,531 1
A2MG_HUMAN Alpha-2-macroglobulin 2 134 163,175 3
AACT_HUMAN Alpha-1-antichymotrypsin 4 240 47,621 6
ANXA1_HUMAN Annexin A1 5 245 38,690 7
ANXA2_HUMAN Annexin A2 5 539 38,580 14
CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 2-3 75 76,748 1
CATD_HUMAN Cathepsin D 4 102 44,524 6
CD59_HUMAN CD59 glycoprotein 9-10 121 14,168 5
CERU_HUMAN Ceruloplasmin 2 85 122,128 3
CLUS_HUMAN Clusterin 3-4 167 52,461 3
CFAH_HUMAN Complement factor H 2 58 139,005 1
CFAI_HUMAN Complement factor I 3 64 65,677 1
CO3_HUMAN Complement C3 1 1,453 187,030 38
CYTB_HUMAN Cystatin-B 10 91 11,133 2
DDEF2_HUMAN Development and differentiation-enhancing factor 2 2 45 111,581 2
ENOA_HUMAN Alpha-enolase (Enolase 1) 4 110 47,139 2
EZRI_HUMAN Ezrin 3 105 69,370 2
FBLN3_HUMAN EGF-containing fibulin-like extracellular matrix protein 1 3-4 39 54,604 1
FETUA_HUMAN Alpha-2-HS-glycoprotein (Fetuin A) 5 142 39,300 3
ALDOA_HUMAN Fructose-bisphosphate aldolase A 5 76 39,395 1
LG3BP_HUMAN Galectin-3-binding protein 3 120 65,289 5
GELS_HUMAN Gelsolin 2 293 85,644 10
G3P_HUMAN Glyceraldehyde-3-phosphate dehydrogenase 5 187 36,030 4
GSTM1_HUMAN Glutathione S-transferase Mu 1 6 128 25,695 6
GSTM2_HUMAN Glutathione S-transferase Mu 2 6 168 25,728 6
GSTM3_HUMAN Glutathione S-transferase Mu 3 6 180 26,542 9
GSTM5_HUMAN Glutathione S-transferase Mu 5 6 172 25,658 7
GSTMP1_HUMAN Glutathione S-transferase P 6-7 53 23,341 1
HBA_HUMAN Hemoglobin subunit alpha 9 56 15,248 1
INADL_HUMAN InaD-like protein 1 53 196,247 1
ITIH2_HUMAN Inter-alpha-trypsin inhibitor heavy chain H2 2 112 106,370 2
LDHA_HUMAN L-lactate dehydrogenase A chain 5 131 36,665 3
LDHB_HUMAN L-lactate dehydrogenase B chain 5 114 36,615 2
TRFL_HUMAN Lactotransferrin (Lactoferrin) 2 100 78,132 7
LPLC1_HUMAN Long palate, lung and nasal epithelium clone protein 1 3-4 1,188 52,408 36
MUC1_HUMAN Mucin-1 1 131 121,999 3
MUC4_HUMAN Mucin-4 1 131 231,440 3
MUC5B_HUMAN Mucin-5B 1 1,207 590,122 27
MUC16_HUMAN Mucin-16 1 56 2,351,813 2
NGAL_HUMAN Neutrophil gelatinase-associated lipocalin 7 344 22,574 12
PRDX1_HUMAN Peroxiredoxin-1 7 125 22,096 4
PEDF_HUMAN Pigment epithelium-derived factor 4 187 46,313 5
PIGR_HUMAN Polymeric immunoglobulin receptor 2 999 83,232 24
PLUNC_HUMAN Protein PLUNC 6 438 26,696 13
S100P_HUMAN Protein S100-P (S100 calcium binding protein P) 10 118 10,393 3
S10A6_HUMAN Protein S100-A6 (S100 calcium binding protein A6) 10 48 10,173 2
S10A8_HUMAN Protein S100-A8 (S100 calcium binding protein A8) 10 61 10,828 2
S10AB_HUMAN Protein S100-A11 (S100 calcium binding protein A11) 10 41 11,733 1
S10AG_HUMAN Protein S100-A16 (S100 calcium binding protein A16) 10 42 11,794 1
RAB1A_HUMAN Ras-related protein Rab-1A 7-8 100 22,663 2
RAB1B_HUMAN Ras-related protein Rap-1B 7-8 118 20,812 3
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simply constitute membrane-bound proteins that pas-
sively adhere to the mucins, although other membrane
components, such as lipids, were not identified. Further,
given that the apical washings were dialyzed against dis-
tilled water, we cannot exclude the possibility that some
of the identified polypeptides are intracellular proteins
from sloughed cells and thus are not necessarily compo-
nents of airway mucus. We also cannot rule out that
our results may not reflect the proteome of in vivo air-
way lining fluid given the probable contributions of
other cell types and blood-borne proteins that were not
present in the NHBE cell cultures. However, the contri-
bution of the cell culture media appears negligible since
serum albumin, the most abundant protein in culture
media, was not identified in the current analysis.
The presence of MUC1, MUC4, MUC5B, and MUC16
in in vitro hAECS confirms prior studies of mucin gly-
coprotein secretion by human and animal airway epithe-
lial cell cultures [13-19]. Mucins constitute the main
protein components of mucus and provide a multifa-
ceted function to the mucosal surface from which they
are produced, ranging from lubrication to cell signaling
to forming protective physical barriers against chemical
or biological damage [4-6]. But whether or not these
functions are provided by mucins alone or in association
with other proteins remains an unanswered question,
which we and others [18,19] have attempted to address.
Specifically, several reports have promoted the concept
that the association between mucins and other proteins
plays a vital role in defense of the respiratory and gas-
trointestinal mucosa against microbial infections
[23-25], including an early model put forth for mucin-
protein interactions in lung mucus by Rose et al. [26].
The inability to identify MUC5AC mucin by proteo-
mic analysis may have been due to insensitivity of the
detection instrumentation, incomplete trypsin diges-
tion, a relatively low abundance of this protein, and/or
failure of TCA to precipitate MUC5AC. Other proteo-
mic studies of hAECS collected from in vitro cell cul-
tures have demonstrated that MUC5B is the
predominant mucin with much lesser amounts of
MUC5AC [19]. By microarray hybridization analysis,
expression of MUC1 and MUC5B mucins, but not
MUC5AC, were up-regulated during ALI culture of
human bronchial epithelial cells [27]. Therefore, these
or other technical artifacts are the most likely explana-
tion for the current result given that MUC5AC was
clearly present in the hAECS by Western blot analysis
and the fact that our prior study identified human
MUC5AC in the spent culture medium of A549 lung
epithelial cells and rat Muc5ac in apical washings of
primary tracheal epithelial cell cultures at an ALI [28].
Table 1 Proteins identified in the V0 fraction of hAECS following SDS-PAGE (Continued)
TIMP1_HUMAN Tissue inhibitor of metalloproteinase 1 7 74 23,156 1
UB2D2_HUMAN Ubiquitin-conjugating enzyme E2 D2 9 40 16,724 2
UB1Q_HUMAN Ubiquitin (ribosomal protein S27a) 10 154 8,560 3
VTDB_HUMAN Vitamin D-binding protein 3-4 142 52,929 2
aSDS-PAGE gel slice number (1 [top] - 10 [bottom]) from which the protein was isolated.
bIon Score, probability value that an observed peptide match is a true match; cuttoff value = 10.
cTheoretical molecular weight from Swiss-Prot database.
dNumber of tryptic peptides generated that match the mass of theoretical trypsin peptides.
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Figure 3 MUC5AC Western blot analysis. Equal protein aliquots
(100 μg) of lysates of NHBE cells, COS-7 cells (negative control), or
hAECS from NHBE cells were resolved by agarose gel
electrophoresis, transferred to PVDF membrane, and reacted with
anti-MUC5AC antibody (45M1). The positions of MUC5AC and the
250 kDa marker protein are shown on the right.
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Cell adhesion molecule (2)
Carcinoembryonic antigen-related cell adhesion molecule 5;
EGF-containing fibulin-like extracellular matrix protein 1
Cell junction protein (1)
InaD-like protein
Cytoskeletal protein (3)
Ezrin; Gelsolin; InaD-like protein  
Defense/immunity protein (6)
Complement C3; Complement factor H; Complement factor I;
Long palate, lung and nasal epithelium carcinoma-associated protein 1;
Polymeric immunoglobulin receptor; Protein Plunc
Extracellular matrix (3)
Alpha-2-HS-glycoprotein; EGF-containing fibulin-like extracellular matrix protein 1;
Mucin-5B
Hydrolase (1)
Complement factor I
Ligase (1)
Ubiquitin-conjugating enzyme E2 D2
Lyase (2)
Alpha-Enolase; Fructose-bisphosphate aldolase A
Miscellaneous function (1)
Lactotransferrin
Molecular function unclassified (5)
Clusterin; Glyceraldehyde-3-phosphate dehydrogenase; Mucin-1; Mucin-4; Mucin-16
Nucleic acid binding (2)
Development and differentiation-enhancing factor 2; Ubiquitin
Oxidoreductase (4)
Ceruloplasmin ; L-lactate dehydrogenase A chain;
L-lactate dehydrogenase B chain; Peroxiredoxin-1
Heme containing protein (1)
Hemoglobin alpha subunit
Protease (3)
Cathepsin D; Complement factor I; Lactotransferrin
Receptor (2)
Galectin-3-binding protein;
Polymeric immunoglobulin receptor
Select calcium binding protein (9)
Annexin A1; Annexin A2;
EGF-containing fibulin-like extracellular matrix protein 1;
Gelsolin; Protein S100-P; Protein S100-A6; Protein S100-A8;
Protein S100-A11;  Protein S100-A16
Select regulatory molecule (11)
Alpha-2-antiplasmin; Alpha-2-macroglobulin; Alpha-1-antichymotrypsin; 
Alpha-2-HS-glycoprotein; Cystatin-B;
Development and differentiation-enhancing factor 2;
Inter-alpha-trypsin inhibitor heavy chain H2;
Ras-related protein Rab-1A; Ras-related protein Rap-1B;
Tissue inhibitor of metalloproteinase 1
Signaling molecule (5)
Alpha-2-macroglobulin; CD59 glycoprotein;
EGF-containing fibulin-like extracellular matrix protein 1;
Protein S100-A6; Protein S100-A11
Transfer/carrier protein (6)
Annexin A1;  Annexin A2; Ceruloplasmin; Lactotransferrin;
Neutrophil gelatinase-associated lipocalin;
Vitamin D-binding protein
Transferase (5)
Glutathione S-transferase Mu 1;
Glutathione S-transferase Mu 2;
Glutathione S-transferase Mu 3;
Glutathione S-transferase Mu 5;
Glutathione S-transferase P
Transporter (3)
Ceruloplasmin;
Long palate, lung and nasal epithelium carcinoma-associated protein 1;
Protein Plunc
Figure 4 Pie chart of molecular functions of proteins in high molecular weight hAECS identified by nano-LC-IT MS. Proteins are listed
by category, number of proteins in the category and specific proteins identified.
Cell structure and motility (6)
Annexin A1; Annexin A2;
Development and differentiation-enhancing factor 2;
Ezrin; Gelsolin; Protein S100-A8
Apoptosis (1) 
Clusterin
Biological process unclassified (6)
Glyceraldehyde-3-phosphate dehydrogenase; Mucin-1; Mucin-4; Mucin-16;
Protein S100-P; Protein S100-A16
Carbohydrate metabolism (4)
Alpha-Enolase; Fructose-bisphosphate aldolase A;
L-lactate dehydrogenase A chain; L-lactate dehydrogenase B chain
Cell adhesion (3)
Carcinoembryonic antigen-related cell adhesion molecule 5; 
Development and differentiation-enhancing factor 2; Ras-related protein Rap-1B
Cell cycle (2)
Protein S100-A6; Protein S100-A11
Cell proliferation and differentiation (1)
Protein S100-A6
Coenzyme and prosthetic group metabolism (1)
Vitamin D-binding protein
Developmental processes (5)
Alpha-2-HS-glycoprotein; Annexin A2;
EGF-containing fibulin-like extracellular matrix protein 1; Mucin-5B; 
Tissue inhibitor of metalloproteinase 1
Homeostasis (1)
Ceruloplasmin
Defense/Immunity  (18)
Alpha-2-HS-glycoprotein; Alpha-2-macroglobulin; Carcinoembryonic antigen-related cell adhesion molecule 5; CD59 glycoprotein;
Complement C3; Complement factor H; Complement factor I; Galectin-3-binding protein; Glutathione S-transferase Mu 1;
Glutathione S-transferase Mu 2; Glutathione S-transferase Mu 3; Glutathione S-transferase Mu 5; Glutathione S-transferase P;
Long palate, lung and nasal epithelium carcinoma-associated protein 1; Neutrophil gelatinase-associated lipocalin;
Peroxiredoxin-1; Polymeric immunoglobulin receptor; Protein S100-A8
Intracellular protein traffic (3)
Annexin A2;  Polymeric immunoglobulin receptor; Ras-related protein Rab-1A
Lipid, fatty acid and steroid metabolism (1)
Annexin A1
Miscellaneous (1)
Lactotransferrin
Nucleoside, nucleotide and nucleic acid metabolism (1)
Protein S100-A11
Oncogenesis (2)
Protein S100-A11; Neutrophil gelatinase-associated lipocalin
Protein metabolism and modification (11)
Alpha-2-antiplasmin; Alpha-2-macroglobulin; Alpha-1-antichymotrypsin;
Alpha-2-HS-glycoprotein; Cathepsin D; Complement factor I; Cystatin-B;
Inter-alpha-trypsin inhibitor heavy chain H2;
Tissue inhibitor of metalloproteinase 1;
Ubiquitin-conjugating enzyme E2 D2; Ubiquitin
Protein targeting and localization (1)
InaD-like protein
Sensory perception (1)
EGF-containing fibulin-like extracellular matrix protein 1
Signal transduction (9)
Alpha-2-macroglobulin; Annexin A1; Carcinoembryonic antigen-related cell adhesion molecule 5;
Development and differentiation-enhancing factor 2;
EGF-containing fibulin-like extracellular matrix protein 1; Galectin-3-binding protein;
Hemoglobin subunit alpha; Protein S100-A6; Ras-related protein Rap-1B
Transport (3)
Hemoglobin subunit alpha; Lactotransferrin;
Neutrophil gelatinase-associated lipocalin;
Vitamin D-binding protein
Figure 5 Pie chart of biological functions of proteins in high molecular weight hAECS identified by nano-LC-IT MS. Proteins are listed by
category, number of proteins in the category and specific proteins identified.
Ali et al. Proteome Science 2011, 9:4
http://www.proteomesci.com/content/9/1/4
Page 7 of 10
The family of proteins identified in this study were
categorized according to molecular and biological func-
tions by Pather analysis. According to the original defi-
nitions of Gene Ontology by Ashburner et al. [29],
molecular function is defined as the elemental activity of
a gene product at the molecular level, such as binding
or catalysis, while a biological function refers to the col-
lected operations or sets of molecular events with a
defined beginning and end, and pertinent to the func-
tioning of integrated living units (cells, tissues, organs,
and organisms). A biological function is accomplished
via one or more ordered assemblies of molecular func-
tions. In this study, the molecular functions associated
with the greatest number of proteins that were identified
in the high molecular weight fraction of the hAECS
samples were regulatory (11 proteins), calcium binding
(9 proteins), transfer/carrier (6 proteins), and defense/
immunity (6 proteins). The biological functions asso-
ciated with the greatest number of proteins were
defense/immunity (18 proteins), protein metabolism and
modification (11 proteins), and signal transduction
(9 proteins). As noted above, some of these functions
have been previously ascribed to airway mucins.
In addition, this collection of proteins could be further
classified into inflammatory, anti-inflammatory, anti-oxi-
dative, and anti-microbial categories based upon search
of the published literature and molecular/biological
function analyses. Some of the proteins fall into more
than one category because they perform more than one
function. For example, protease inhibitors may act both
as inflammatory and anti-inflammatory components of
mucus, depending upon the context of their expression
[21]. Protease inhibitors that were identified in the pre-
sent study were alpha-1-antichymotrypsin, alpha-2-
macroglobulin, alpha-2-antiplasmin, inter-alpha-trypsin
inhibitor heavy chain H2, pigment epithelium-derived
factor, cystatin-B, and tissue inhibitor of metalloprotei-
nase 1. Many of these proteins have been shown to reg-
ulate protease activities in various diseases that afflict
airway epithelia [30-35].
The anti-oxidative proteins identified herein were cer-
uloplasmin, clusterin, glutathione S-transferase (GST),
pigment epithelium-derived factor, peroxiredoxin 1
(Prdx1), lactate dehydrogenase, lactotransferrin, ubiqui-
tin, and ubiquitin-conjugating enzyme E2 D2. Amongst
these, GST and Prdx1 are probably the best character-
ized in the respiratory tract. GST provides redox balance
in response to production of reactive oxygen species and
has been reported to be involved in host defense in the
lung [36]. The Prdx family of anti-oxidant enzymes
reduces peroxides, lipid hydroperoxides and peroxyni-
trites, and the role of Prdx1 in airway inflammation has
been reviewed [37]. Within the group of anti-microbial
proteins, CD59 is involved in inflammatory signal trans-
duction in T cells in response to pathogenic insults [38],
while components of the complement system act as
antibiotic components during host defense against bac-
teria that commonly infect the respiratory tract,
Mucins 
(MUC1, MUC4, MUC5AC, MUC5B, MUC16)
Responsible for viscoelastic nature of mucus.
Aid in mucociliary clearance of foreign bodies.
Act as anti-inflammatory and anti-microbial molecules.
Provide defense to the upper and lower respiratory tracts.
Anti-oxidative
Ceruloplasmin
Clusterin
Glutathione S-transferase Mu 1 
Glutathione S-transferase Mu 2 
Glutathione S-transferase Mu 3 
Glutathione S-transferase Mu 5 
Glutathione S-transferase P 
L-lactate dehydrogenase A chain
L-lactate dehydrogenase B chain
Pigment epithelium-derived factor 
Peroxiredoxin 1 
Lactotransferrin (Lactoferrin)
Anti-microbial
Carcinoembryonic antigen-related cell adhesion molecule 5
Cathepsin D
CD59 glycoprotein
Complement factor H
Complement factor I
Complement C3
Glyceraldehyde-3-phosphate dehydrogenase
L-lactate dehydrogenase B chain
Lactotransferrin (Lactoferrin)
Long palate, lung and nasal epithelium carcinoma-associated protein 1
Neutrophil gelatinase-associated lipocalin
Protein Plunc
Protein S100-P (S100 Calcium binding protein P)
Protein S100-A6 (S100 Calcium binding protein A 6)
Protein S100-A8 (S100 Calcium binding protein A 8)
Protein S100-A11 (S100 Calcium binding protein A11)
Protein S100-A16 (S100 Calcium binding protein A16)
Vitamin D-binding protein
Anti-inflammatory
Alpha-1-antichymotrypsin
Alpha-2-macroglobulin 
Alpha-2-antiplasmin 
Inter-alpha-trypsin inhibitor heavy chain H2 
Pigment epithelium-derived factor
Alpha-enolase
CD59 glycoprotein
Carcinoembryonic antigen-related cell adhesion molecule 5
Ceruloplasmin
Clusterin
Complement factor H
Complement factor I
Complement C3
Cystatin-B
Galectin-3-binding protein
Lactotransferrin (Lactoferrin)
Long palate, lung and nasal epithelium carcinoma-associated protein 1
Protein Plunc
Protein S100-P (S100 Calcium binding protein P) 
Protein S100-A6 (S100 Calcium binding protein A 6) 
Protein S100-A8 (S100 Calcium binding protein A 8) 
Protein S100-A11 (S100 Calcium binding protein A11) 
Protein S100-A16 (S100 Calcium binding protein A16) 
Tissue inhibitor of metalloproteinase 1
Anti-protease
Alpha-1-antichymotrypsin
Alpha-2-macroglobulin 
Alpha-2-antiplasmin
Inter-alpha-trypsin inhibitor heavy chain H2
Pigment epithelium-derived factor
Cystatin-B
Figure 6 Categorization of proteins in high molecular weight hAECS identified by nano-LC-IT MS.
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including Pseudomonas aeruginosa, Klebsiella pneumo-
niae, and Streptococcus pneumoniae [39-41]. The palate,
lung and nasal epithelial clone (PLUNC) family can be
subdivided into short (SPLUNC) and long (LPLUNC)
proteins [42]. In this classification, the original protein
called PLUNC is now SPLUNC1, which is expressed in
sub-mucosal glands of normal individuals and expres-
sion is increased in cystic fibrosis lungs, especially in the
surface epithelia of the conducting airways. PLUNC was
reported to protect the airway epithelial sodium channel
(ENaC) from proteolytic cleavage, to prevent respiratory
infections, and to inhibit lung allergic responses [43,44].
Finally, the S100 series of Ca2+ binding proteins are
highly expressed in neutrophils and monocytes [45,46]
and have been reported as anti-microbial agents against
P. aeruginosa [47] as well as novel TLR ligands impor-
tant in modulating inflammation [45,48].
Conclusion
We identified 55 proteins that were present in the high
molecular weight fraction of in vitro human airway
epithelial cell apical secretions isolated under physiolo-
gical conditions. Among the mucin gene products that
were identified were MUC1, MUC4, MUC5B, and
MUC16. By proteomic analysis, these proteins could
be classified as inflammatory, anti-inflammatory, anti-
oxidative, and/or anti-microbial. Given that the major-
ity of these proteins in their monomeric form possess
molecular weights far less than that selected for analy-
sis, it is theoretically possible that they may associate
with the highly sialylated and negatively charged
mucins through ionic and hydrophobic interactions to
form a highly ordered structural organization that may
be important for maintaining the proper function of
airway mucus.
List of abbreviations used
ALI: air-liquid interface; ESI: electrospray ionization; hAECS: human airway
epithelial cell secretion; kDa: kiloDalton; MS: mass spectrometry; Mol Wt:
molecular weight; MUC: mucin; NHBE: normal human bronchial epithelial;
SDS-PAGE: sodium dodecyl sulfate-polyacrylamide gel electrophoresis
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